Retraction Note to: Linc‑ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR‑124/PTBP1/PKM2 axis

被引：0
|
作者：
Chenggang Li
Zhiming Zhao
Zhipeng Zhou
Rong Liu
机构：
[1] Chinese PLA General Hospital,Department of Surgical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 89卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：149 / 149
相关论文
共 15 条
  • [1] RETRACTED ARTICLE: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis
    Chenggang Li
    Zhiming Zhao
    Zhipeng Zhou
    Rong Liu
    Cancer Chemotherapy and Pharmacology, 2016, 78 : 1199 - 1207
  • [2] RETRACTION: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis (Retraction of Vol 78, Pg 1199, 2016)
    Li, Chenggang
    Zhao, Zhiming
    Zhou, Zhipeng
    Liu, Rong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 149 - 149
  • [3] RETRACTED: Linc-ROR confers gemcitabine resistance to pancreatic cancer cells via inducing autophagy and modulating the miR-124/PTBP1/PKM2 axis (Retracted article. See vol. 89, pg. 149, 2022)
    Li, Chenggang
    Zhao, Zhiming
    Zhou, Zhipeng
    Liu, Rong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1199 - 1207
  • [4] Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
    S Calabretta
    P Bielli
    I Passacantilli
    E Pilozzi
    V Fendrich
    G Capurso
    G Delle Fave
    C Sette
    Oncogene, 2016, 35 : 2031 - 2039
  • [5] Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells
    Calabretta, S.
    Bielli, P.
    Passacantilli, I.
    Pilozzi, E.
    Fendrich, V.
    Capurso, G.
    Delle Fave, G.
    Sette, C.
    ONCOGENE, 2016, 35 (16) : 2031 - 2039
  • [6] CSNK2A1 confers gemcitabine resistance to pancreatic ductal adenocarcinoma via inducing autophagy
    Liu, Zhi-De
    Shi, Yin-Hao
    Xu, Qiong-Cong
    Zhao, Guang-Yin
    Zhu, Ying-Qin
    Ma, Ming-Jian
    Ye, Jing-Yuan
    Xu, Xiang
    Wang, Jie-Qin
    Zhao, Wei
    Yin, Xiao-Yu
    CANCER LETTERS, 2024, 585
  • [7] LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1
    Zheng, Hailun
    Zhang, Mei
    Ke, Xiquan
    Deng, Xiaojing
    Li, Dapeng
    Wang, Qizhi
    Yan, Shanjun
    Xue, Yongju
    Wang, Qiangwu
    CANCER BIOMARKERS, 2021, 30 (04) : 395 - 406
  • [8] The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy
    Yuan, Peng
    Cao, Weibin
    Zang, Quanling
    Li, Guixin
    Guo, Xiangfei
    Fan, Jianghe
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (03) : 1067 - 1073
  • [9] Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis
    Chi, Yuan
    Xin, He
    Liu, Zhaoyu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
    Wang, Y.
    Wang, X.
    Han, L.
    Hu, D.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457
12